Search NLS News

For six months, starting in January 2023, Sweden has the Presidency of the Council of the European Union. It is much more than an honorary role, encompassing an opportunity for Sweden to both influence new guidelines and to drive to completion the implementation of important existing policies – not least those relevant for our industry. […]

Do you want to work with interesting clinical research projects with dedicated and experienced colleagues? We are in an expansion phase and currently seeking a Pharma Group Manager/Project Manager with experience working with clinical studies.   Gruppchef/Projektledare till kliniska prövningsgruppen på Scandinavian CRO Scandinavian CRO (SCRO) är en ”full-service Contract Research Organisation” (CRO) med kontor […]

Novo Nordisk has announced it is lowering the US list prices of several insulin products by up to 75% for people living with type 1 and type 2 diabetes. Products include both pre-filled pens and vials of basal (long-acting), bolus (short-acting) and pre-mix insulins, specifically Levemir, Novolin, NovoLog and NovoLog Mix 70/30. Novo Nordisk is […]

Pfizer and Seagen have entered into a definitive merger agreement under which Pfizer will acquire Seagen for 229 USD in cash per Seagen share for a total enterprise value of 43 billion USD. “Together, Pfizer and Seagen seek to accelerate the next generation of cancer breakthroughs and bring new solutions to patients by combining the […]

The EpiShuttle is approved by the Therapeutic Goods Administration (TGA) and is now fully available for use in the Australian market. “Even though The EpiShuttle has been with RAAF for some time now, we are happy to see that the safe isolation and transport system now fully available to the civil Australian market,” says Michael […]

Tuuli Lappalainen, the Director of the National Genomics Infrastructure at SciLifeLab and Professor in genomics at KTH, recently received the Göran Gustafsson award for her research on the impact of genetic differences on gene expression regulation. Tuuli Lappalainen’s research group is investigating the role of genes and the environment in shaping human diversity. Small differences […]

The company has announced that the first patient was dosed in a trial evaluating bemcentinib in combination with the current standard of care, immune checkpoint inhibitor pembrolizumab and doublet chemotherapy, for the treatment of 1st line (1L) Non-Small Cell Lung Cancer (NSCLC) patients harboring STK11 mutations (STK11m). “Approximately 20% of non-squamous NSCLC patients harbor STK11m […]

Calliditas Therapeutics has announced results from the global, randomized, double-blind, placebo-controlled Phase 3 clinical trial NefIgArd, which investigated the effect of Nefecon versus placebo in patients with primary IgA nephropathy. The trial met its primary endpoint with Nefecon demonstrating a highly statistically significant benefit over placebo in estimated glomerular filtration rate (eGFR) over the two-year […]

Jessica Martinsson took up her new role as Director General of SwedenBIO on March 1st 2023. NLS asked Jessica about her previous experiences from the life science industry and about current challenges and opportunities for Swedish life science companies. You are the co-founder of, and you have been both operational manager and CEO of Sprint […]

Medicon Valley, the coalition of the willing and a renaissance for Nordic collaboration? When tectonic plates shift, landscapes changes and mountain and valleys are created. Politically the tectonic plates in the Nordics are shifting dramatically with Finland and Sweden opting for NATO-membership as a direct consequence of the war in Ukraine and the fear of […]